English | Español
Patient Daily | Dec 8, 2025

New AML guidelines highlight improved outcomes for older adults through personalized treatments
Patient Daily | Dec 8, 2025

Advances in screening shift perception of lung cancer toward treatability
Patient Daily | Dec 8, 2025

ENT & Allergy Associates of Texas adds fellowship-trained rhinologist Karen Bednarski to Katy office
Patient Daily | Dec 8, 2025

HiArc president discusses strategies for avoiding pitfalls in diagnostic product development
Patient Daily | Dec 8, 2025

ATM kinase identified as main regulator in cell aging and cancer prevention
Patient Daily | Dec 8, 2025

Researchers find global spread of hidden antibiotic-resistant bacteria
Patient Daily | Dec 8, 2025

Researchers map epilepsy drug binding sites on key brain protein
Patient Daily | Dec 8, 2025

FDA’s shift from QSR to QMSR brings new focus on risk for drug delivery devices

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'